| Date | Title | Description |
| 31.10.2024 | Navigating the Future of Healthcare: Insights from Recent Developments in Regulatory Translation and Neurodegenerative Research | In the fast-paced world of healthcare, clarity is king. Recent developments in regulatory translation management and neurodegenerative disease research highlight the importance of precision and innovation. These two areas, while distinct, s... |
| 29.10.2024 | GemVax Announces Topline Results from Phase 2a Progressive Supranuclear Palsy Clinical Trial at Neuro2024 | - Topline supports moving to Phase 3 trial and shows potential to develop GV1001 as the world's first PSP treatment
SEOUL, South Korea, Oct. 29, 2024 /PRNewswire/ -- GemVax & KAEL Co., Ltd. ("GemVax"; KOSDAQ ticker: 082270) an... |
| 28.10.2024 | Unlocking global strategies with proactive regulatory translation management, upcoming webinar hosted by Xtalks | www.iconplc.com
In this free webinar, learn best practices for integrating translations into global submission strategies. Attendees will learn about the importance of accurate translations. The featured speakers will discuss common challen... |
| 08.10.2024 | Dosimetry in clinical trials, Upcoming Webinar Hosted by Xtalks | www.iconplc.com
In this free webinar, learn about the different lesion- and organ-based dosimetry approaches, including dose-response correlations, dose-volume histograms and dose heterogeneity maps. Attendees will learn how dosimetry helps... |
| 02.10.2024 | Pfizer's Strategic Shift: Selling Haleon Shares and Precision Medicine's New Leadership | In the ever-evolving landscape of pharmaceuticals, companies often pivot to stay ahead. Pfizer is making waves again. The pharmaceutical giant has announced a significant move: selling its stake in Haleon, the maker of Sensodyne, for a stag... |
| 01.10.2024 | Precision Medicine Group Welcomes Margaret Keegan as CEO | -- Founding CEO Mark Clein named Executive Chairman; Mr. Clein and co-founder Ethan Leder to continue as Board Directors --
BETHESDA, Md., Oct. 1, 2024 /PRNewswire/ -- Precision Medicine Group (Precision), a leading next-generation provider... |
| 25.09.2024 | Changes to the FDA guidance on Data Monitoring Committees in clinical trials, Upcoming Webinar Hosted by Xtalks | www.iconplc.com
In this free webinar, stay informed about the new draft US Food and Drug Administration (FDA) guidance on the use of data monitoring committees (DMCs) in clinical trials. Attendees will learn about new requirements for commi... |
| 12.09.2024 | Continuous long term cardiovascular monitoring in clinical trials, upcoming webinar hosted by Xtalks | www.iconplc.com
In this free webinar, gain insights into the transformative impact of long-term cardiovascular monitoring technologies on clinical trials. Attendees will learn about the definition of long-term cardiovascular data and the ne... |
| 05.09.2024 | Medicare Part D price negotiation update, Upcoming Webinar Hosted by Xtalks | www.iconplc.com
In this free webinar, learn about the ongoing legal challenges initiated by pharmaceutical companies and other stakeholders against the Inflation Reduction Act's price negotiation provisions. Attendees will learn about the d... |
| 19.08.2024 | Mastering RMPs and RMMs: Tech-driven solutions for patient safety, Upcoming Webinar Hosted by Xtalks | www.iconplc.com
In this free webinar, learn how pharmacovigilance professionals can apply practical solutions and advanced technologies to enhance their ability to efficiently monitor and respond to risks, ensure regulatory compliance, impr... |
| 16.08.2024 | Navigating the Regulatory Labyrinth: Insights from Upcoming Webinars on Drug Submissions and Oligonucleotide Therapeutics | The world of pharmaceuticals is a complex maze. Regulatory submissions are the keys that unlock the doors to market approval. In this intricate landscape, two upcoming webinars promise to shed light on crucial aspects of drug development: r... |
| 15.08.2024 | Regulatory Submission Writing for NDA Success, Upcoming Webinar Hosted by Xtalks | www.iconplc.com
In this free webinar, learn about the regulatory submission process, the various types of submissions and how medical writing contributes to each stage. Attendees will learn about common requirements for technical documents ... |
| 12.08.2024 | Considerations for Oligonucleotide Therapeutics in CMC, Upcoming Webinar Hosted by Xtalks | www.iconplc.com
In this free webinar, learn about the production process and drug substance specifications for oligonucleotide therapeutics. Attendees will learn about chemistry, manufacturing and control (CMC) Investigational Medicinal Pro... |
| 03.06.2024 | Unlocking precision medicine: An overview of Illumina's TSO500, Upcoming Webinar Hosted by Xtalks | www.iconplc.com
In this free webinar, learn about comprehensive genomic profiling (CGP) and the application of next-generation sequencing in oncology clinical trial biomarker studies. Attendees will gain insights into TruSight Oncology 500 ... |
| 16.05.2024 | Diamyd Medical updates on the registrational Phase 3 trial; upcoming interim analysis and enrollment | Diamyd Medical updates on the registrational Phase 3 trial; upcoming interim analysis and enrollment
Thu, May 16, 2024 10:15 CET Report this content
Interim Analysis outcome scheduled for beginning of August
The Interim Analysis will be con... |
| 22.04.2024 | Moody's: Don't expect many large health deals in 2024 | figcaption>span]:font-sans">
Anyone hoping for merger madness in health care this year will have to defer those dreams, a recent Moody's report suggests.
The big picture: Transformative M&A, particularly in the payer and prov... |
| 12.03.2024 | Real World Evidence/RWE Solutions Market is growing at a CAGR of 13.8% from 2024 to 2030 by Exactitude Consultancy | Real World Evidence (RWE) Solutions market
The Exactitude Consultancy Real World Evidence/RWE Solutions Market Report – Size, Trends, and Forecast 2024-2030
The Real World Evidence (RWE) Solutions market is experiencing high demand due to i... |
| 11.03.2024 | Patient Recruitment and Retention Services Global Market Report 2024 | - |
| 07.03.2024 | Oncology-Based In-Vivo CRO Market Projected for Vigorous Growth, North America Leads Regional Shares | - |
| 06.03.2024 | Practical Guidance for Successful Global Regulatory Submissions: Understanding FDA and PMDA Data Standards Requirements, Upcoming Webinar Hosted by Xtalks | www.iconplc.com
In this free webinar, gain insights into the constantly evolving data standards requirements for regulatory submissions. The US Food and Drug Administration (FDA) and Japan's Pharmaceuticals and Medical Devices Agency (PMDA)... |
| 02.08.2023 | Advancements in AI for optimal clinical trial site identification: Turning Big Data into actionable intel, upcoming webinar hosted by Xtalks | Xtalks Life Science Webinars Roles focusing on site identification and selection, clinical operations, procurement/outsourcing and quality/compliance will find the content particularly insightful.
Toronto, ON (PRWEB) August 02, 2023
A new w... |
| 11.05.2023 | Navigating the new EU CTR regulations in early phase clinical trials, Upcoming Webinar Hosted by Xtalks | Register for this webinar on the EU CTR process to gain valuable insights on how to avoid pitfalls in the early phase clinical trial submissions and navigate the regulatory review process efficiently.
TORONTO (PRWEB) May 11, 2023
This webin... |
| 11.04.2023 | Exploring Partnership Culture and its Impact on Outsourcing and Operational Strategy, Upcoming Webinar Hosted by Xtalks | Register for this webinar to gain insights into partnership/alliance culture and its impact on outsourcing and operational strategy.
TORONTO (PRWEB) April 11, 2023
Business strategist Peter Drucker famously said that “culture eats strategy ... |
| 08.03.2023 | Challenges in Assessing Long-Term Effects of Covid and Covid Vaccines, Upcoming Webinar Hosted by Xtalks | While information on the known risks is available in the Risk Management Plans (RMPs), missing information include the use in pregnancy, immunocompromised patients, patients with comorbidities, autoimmune or inflammatory diseases and long-t... |
| 07.03.2023 | Rare Disease Week 2023: Exploring Accessibility in Rare Disease Clinical Research, 4-Day Webinar Series Hosted by Xtalks | Will provide insights into the value of accessibility in rare disease clinical research and how sponsors, patient advocates, researchers and regulators might move from discussion to action.
TORONTO (PRWEB) March 07, 2023
Each panel in this ... |
| 20.12.2022 |
MDR reportedly causing medtech companies to leave EU market | The EU’s new Medical Devices Regulation (MDR) has created enough compliance costs that some medtech companies have stopped selling there., according to a report from Reuters.
Reuters spoke with eight companies, including the Swedish medtech... |
| 30.11.2022 | Home Health: Best Practices and Processes to Build Confidence in the Value of In-Home Services, Upcoming Webinar Hosted by Xtalks | While looking to the future of clinical trials and shifting the paradigm to make them more patient-centric and efficient, home health and home-based services promise to be an important component in delivering on this mission.
TORONTO (PRWEB... |
| 21.09.2022 | Keep eCOA Off the Critical Path of Clinical Trial Startup, Upcoming Webinar Hosted by Xtalks | The featured speakers will help attendees achieve study objectives and critical timelines, by providing guidance on how to optimize and carefully manage COAs from initial risk assessment to full implementation.
TORONTO (PRWEB) September 21,... |
| 23.08.2022 | Diversity, Equity and Inclusion in Rare Disease Clinical Trials: Beyond Buzzwords, Upcoming Webinar Hosted by Xtalks | Join the featured speakers for an in-depth, interdisciplinary panel discussion of research leaders and community advocates from BridgeBio, the Duke ALS Clinic, RARE-X and The Sumaira Foundation
TORONTO (PRWEB) August 23, 2022
The rarity of ... |
| 07.03.2022 | Hot Flashes, Brain Fog and the Blues: Frontiers in Menopause Treatments, Upcoming Webinar Hosted by Xtalks | As we understand more about the effects of hormonal changes on women’s physical and mental health throughout their life cycle, a picture emerges highlighting opportunities for research and treatment innovation.
TORONTO (PRWEB) March 07, 202... |
| 24.02.2022 | A Guide to Conducting Clinical Trials in China, Upcoming Webinar Hosted by Xtalks | The Chinese government is also supportive of international partnerships and has introduced an improved regulatory environment for more efficient and accelerated research and new drug approvals.
TORONTO (PRWEB) February 24, 2022
The number o... |
| 18.01.2022 | Longitudinal Qualitative Research: A Powerful Tool for Patient-Centred Research, Upcoming Webinar Hosted by Xtalks | While there are established methods in place for conducting cross-sectional qualitative research, longitudinal qualitative research is a promising and innovative field for which specific methods are not yet well-defined.
TORONTO (PRWEB) Jan... |
| 04.11.2021 | What is the Link Between Pharmacovigilance and Building Confidence Around COVID-19 Vaccines? Upcoming Webinar Hosted by Xtalks | At the end of 2020, between 37 and 44 percent of Americans stated that they would not accept a COVID-19 vaccine, whatever the cost.
TORONTO (PRWEB) November 04, 2021
In 2019, the WHO identified vaccine hesitancy as one of the top ten global... |
| 03.11.2021 | ICON Reports Third Quarter 2021 Results - Form 6-K | ICON Reports Third Quarter 2021 Results
Highlights
Record net business wins in the quarter of $2,374 million; a net book to bill of 1.27.
Closing backlog of $18.6 billion, an increase of 3% on our Combined Company Backlog since the closing ... |
| 28.10.2021 | ICON’s World Children’s Day, Upcoming Webinar Hosted by Xtalks | ICON celebrates World Children’s Day each year to bring our industry together to consider how clinical research contributes to improving the welfare of children and to discuss how we can improve clinical development for these children and t... |
| 21.10.2021 | Reflections on Pediatric Assent: Have We Outgrown This Concept? Upcoming Webinar Hosted by Xtalks | In this webinar, medical ethicists will discuss what investigators, Ethics Committees, IRBs and – ideally – sponsors can do to reverse this trend and create documents which achieve their intended purpose of allowing a child to understand th... |
| 21.09.2021 | Women in Pharma: Navigating the Career Jungle Gym, Upcoming Online Panel Discussion Hosted by Xtalks | Our panel of experts will discuss the increase in female representation in STEM fields, the importance of mentoring and coaching and how the biotech and pharmaceutical industries can support and advance more female leaders.
TORONTO (PRWEB) ... |
| 16.09.2021 | Mini Series on an Approach to Career and Professional Development in FSP Models, Hosted by Xtalks | We identify problems causing an imbalance in the equilibrium and provide a range of practical, testable, operational and training solutions to restore a balance that ensures concurrent benefit to both provider and customer, with successful ... |
| 09.08.2021 | How to Increase Engagement with Medical and Scientific Posters Using Enhanced Digital Content and Design, Upcoming Webinar Hosted by Xtalks | One key consideration is paying attention to shifts in how users prefer to receive information, although this can vary greatly by audience.
TORONTO (PRWEB) August 09, 2021
As in-person scientific congresses are re-inventing themselves into ... |
| 06.08.2021 | Antimicrobial Resistance: How Clinical Research Can Combat an Ensuing Global Crisis, Upcoming Webinar Hosted by Xtalks | Register for the webinar to learn about the antimicrobial resistance crisis and what the biopharma and healthcare industries can do to mitigate the impact of future pandemics.
TORONTO (PRWEB) August 06, 2021
The World Health Organization ha... |
| 05.07.2021 | ICON Acquisition Creates World-Leading Healthcare Intelligence and Clinical Research Organisation | ICON plc, announced the completion of its acquisition of PRA Health Sciences. The combined company will retain the name ICON and will bring together 38,000 employees across 47 countries, creating the world’s most advanced healthcare intelli... |
| 29.06.2021 | Designing and Conducting Effective Long-Term Follow up Studies, Upcoming Webinar Hosted by Xtalks | While stand-alone LTFU studies are not new, the models have evolved with the advent of potentially transformative therapies and treatments, including, but not limited to advanced therapy medical products, cellular products and gene therapie... |
| 14.06.2021 | ICON PUBLIC LIMITED COMPANY
ICON Public : Announces Private Offering of Senior Secured Notes (Form 6-K) | ICON Announces Private Offering of Senior Secured Notes
Dublin, Ireland, June 14, 2021 - ICON plc (NASDAQ: ICLR) ('ICON') announced today in connection with the proposed acquisition by ICON of PRA Health Sciences, Inc. ('PRA') pursuant to w... |
| 14.06.2021 | ICON PUBLIC LIMITED COMPANY
ICON Public : Announces Private Offering of Senior Secured Notes | ICON plc (NASDAQ: ICLR) (“ICON”) announced today in connection with the proposed acquisition by ICON of PRA Health Sciences, Inc. (“PRA”) pursuant to which Indigo Merger Sub, Inc., a wholly owned subsidiary of ICON (“Merger Sub”) will merge... |
| 04.05.2021 | Cardiovascular event adjudication during COVID-19 and beyond, Upcoming Webinar Hosted by Xtalks | Independent event adjudication has the power to enhance the scientific validity of cardiovascular trials by allowing consistent assessment of cardiovascular events and employing standardized definitions across trial sites.
TORONTO (PRWEB) M... |
| 25.03.2021 | The Value of Early-Phase Medical Communication Planning, Upcoming Webinar Hosted by Xtalks | Early initiation of medical communication planning ensures that key stakeholders are well-educated in the therapeutic area, unmet needs, product and key competitors and are aligned on preferred language and strategic objectives.
TORONTO (PR... |
| 19.03.2021 | Transforming CNS Drug Development with Wet Lab and Imaging Biomarker Solutions, Upcoming Webinar Hosted by Xtalks | The complexity of the CNS has caused low success rates in novel drug development for this therapeutic area.
TORONTO (PRWEB) March 19, 2021
Increasing aging populations have contributed to a rise in diagnosis of diseases of the central nervo... |
| 27.02.2021 | Icon To Acquire PRA Health Sciences, for Approx. 12 Billion | Icon plc (NASDAQ: ICLR), a global provider of outsourced drug and device development and commercialization services to the pharmaceutical, biotechnology and medical device industries, and government and public health organisations, is to ac... |
| 15.02.2021 | HIV Treatments: From Antiretroviral Therapy to Vaccines, Upcoming Webinar Hosted by Xtalks | Despite the progress that has been made, elements including HIV disease heterogeneity and geographical variation pose challenges to HIV clinical trials.
TORONTO (PRWEB) February 15, 2021
Since 2010, the world has witnessed significant advan... |
| 17.12.2020 | Managing Safety Reporting in the Evolving Regulatory Environment of the Asia-Pacific Region, Upcoming Webinar Hosted by Xtalks | In the Asia Pacific region specifically regulatory and legal requirements vary from country to country and this is additionally layered by intricate country language requirements.
TORONTO (PRWEB) December 17, 2020
Managing safety cases is b... |
| 01.12.2020 | The IVDR Journey: A Roadmap to Meet 2022 Deadlines, Upcoming Webinar Hosted by Xtalks | Now more than ever, in vitro diagnostic (IVD) manufacturers will need to prepare for the upcoming changes to the clinical and regulatory landscape.
TORONTO (PRWEB) December 01, 2020
Between the COVID-19 pandemic and BREXIT negotiations, the... |
| 08.05.2020 | Ex-AstraZeneca exec Kristen Buck hops aboard Icon as CMO; Immunocore taps Brian DiDonato as CFO | Kristen Buck
→ Prominent CRO player Icon is bolstering its leadership, with Kristen Buck taking the reins as CMO.
For slightly more than a year and a half, Buck was the SVP & chief of clinical development at Optum, part ... |
| 27.12.2019 | Top 60 Health IT/Digital Health Mergers & Acquisitions in 2019 | – From Google’s acquisition of Fitbit to Philips acquisition of Carestream Health’s health IT business, here is a look at some of the biggest health IT/digital health mergers & acquisitions in 2019 by each quarter.Q1 M&A Activity
Jo... |
| 15.02.2018 | Icon reports more expectation-beating results | Medtech, pharma and biotech development outsourcer Icon continues to beat the Street when it comes to its results.
Dublin, Ireland–based Icon (Nasdaq:ICLR) said today that it earned $78.5 million, or $1.43 per share, off $455.1 million in s... |
| 01.03.2012 | INC Research tops CRO quality ranking as M&A shapes pharma outsourcing | Before acquiring Kendle last year, INC was a mid-sized CRO whose size and pharmaceutical outsourcing service offerings fell well short of the largest CROs such as Quintiles and Parexel. Raleigh, North Carolina-based INC’s service quality me... |
| 29.02.2012 | Icon’s PriceSpective acquisition adds drug price expertise to CRO’s portfolio | The PriceSpective deal follows completion of the BeijingWits Medical Consulting acquisition, which adds to Icon’s presence in China. Much of the CRO acquisition activity of the last year has been driven by the desire of large CROs to add sp... |
| 23.12.2011 | A clinical research organization wish list for Christmas (and new year) | A strategic partner: The biggest CROs such as, Quintiles, PPD, and Covance (NYSE:CVD) are increasingly moving toward strategic partnerships, making them a “preferred provider” of services. In these arrangements, a pharma will contract with ... |
| - | The Rainmakers: Meet the 20 heavyweight bankers that orchestrated the biggest deals of 2021 | From left: Naveen Nataraj, cohead of US advisory at Evercore, Anu Aiyengar, global co-head of M&A at JPMorgan, Aryeh Bourkoff, CEO and founder at LionTree Advisors, Kevin Brunner, co-head of global M&A at Bank of America LionTree Ad... |
| - | INC Research tops CRO quality ranking as M&A shapes pharma outsourcing | Among clinical research organizations, INC Research is not the biggest, but by at least one measure, it stands out as the best.
INC received the best service quality scores in the annual CRO quality benchmarking study conducted by Industry ... |
| - | 3 ways biotech companies can overcome funding obstacles | Over the last few years, the biotech space has undergone phenomenal growth. The bioscience industry in particular has grown 7.2% since 2016, with the global biotechnology market size expected to reach $2.44 trillion by 2028.1 Today, one fif... |
| - | Icon’s PriceSpective acquisition adds drug price expertise to CRO’s portfolio | Count Icon (NASDAQ:ICLR) among the clinical research organizations continuing the industry M&A activity.
The Ireland-based CRO has acquired PriceSpective, a CRO with a consulting focus and expertise in drug pricing. Icon didn’t disclose... |
| - | A clinical research organization wish list for Christmas (and new year) | North Carolina clinical research organization PPD got an early Christmas present with the completion of its $3.9 billion acquisition by private equity firms The Carlyle Group and Hellman & Friedman.
Talks about the CRO acquisition began... |
